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Abstract
Background: Measurement of vital signs in hospitalized patients is necessary to assess the clinical situation of the patient. Early
warning scores (EWS), such as the modified early warning score (MEWS), are generally calculated 3 times a day, but these may
not capture early deterioration. A delay in diagnosing deterioration is associated with increased mortality. Continuous monitoring
with wearable devices might detect clinical deterioration at an earlier stage, which allows clinicians to take corrective actions.
Objective: In this pilot study, the feasibility of continuous monitoring using the ViSi Mobile (VM; Sotera Wireless) and
HealthPatch (HP; Vital Connect) was tested, and the experiences of patients and nurses were collected.
Methods: In this feasibility study, 20 patients at the internal medicine and surgical ward were monitored with VM and HP
simultaneously for 2 to 3 days. Technical problems were analyzed. Vital sign measurements by nurses were taken as reference
and compared with vital signs measured by both devices. Patient and nurse experiences were obtained by semistructured interviews.
Results: In total, 86 out of 120 MEWS measurements were used for the analysis. Vital sign measurements by VM and HP were
generally consistent with nurse measurements. In 15% (N=13) and 27% (N=23) of the VM and HP cases respectively, clinically
relevant differences in MEWS were found based on inconsistent respiratory rate registrations. Connection failure was recognized
as a predominant VM artifact (70%). Over 50% of all HP artifacts had an unknown cause, were self-limiting, and never took
longer than 1 hour. The majority of patients, relatives, and nurses were positive about VM and HP.
Conclusions: Both VM and HP are promising for continuously monitoring vital signs in hospitalized patients, if the frequency
and duration of artifacts are reduced. The devices were well received and comfortable for most patients.
(JMIR Mhealth Uhealth 2017;5(7):e91)   doi:10.2196/mhealth.7208
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Introduction
In hospitalized patients, vital signs are measured to assess the
clinical situation of the patient and to identify clinical
deterioration [1]. Monitoring of these vital signs is usually done
by nurses, and includes blood pressure (BP), heart rate (HR),
respiratory rate (RR), blood oxygen saturation, and core
temperature. Early warning scores (EWS) are physiological
track-and-trigger systems, which use a multiparameter or
aggregate weighted scoring system that assists in detecting
physiological changes and thereby identify patients at risk for
further deterioration [2,3]. The modified early warning score
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(MEWS) is a commonly used and validated EWS system (see
Multimedia Appendix 1) [4-6]. A higher MEWS is associated
with admissions to the intensive care unit (ICU), cardiac arrest,
and mortality [7-9]. Since the introduction of EWS, a trend was
seen toward a decrease in unplanned admissions to the ICU and
a decrease in hospital mortality [10-16]. Although the EWS
provides relevant data on patients’ health status, the interval
measurements may not capture early deterioration of vital signs
[17], particularly during the night when clinical deterioration
may remain undetected until the next day [18]. This could
explain why the majority of the unplanned ICU admissions take
place between 8 am and 4 pm [19]. Unplanned ICU admissions
are associated with an increased mortality rate, a longer hospital
stay [20-22], and a 60% increase in hospitalization costs [23].
Continuous monitoring of vital signs could be a useful tool to
detect clinical deterioration in an earlier phase, which allows
clinicians to take corrective interventions, particularly since
subtle changes in vital signs often are present 8 to 24 hours
before a life-threatening event such as ICU admission, cardiac
arrest, and death [13,24-27]. Nowadays, wearable devices that
facilitate remote continuous monitoring of vital signs exist [28].
These wireless devices could reduce patient discomfort due to
fewer measurements by nurses [29-31], allow patient mobility
[31], and might reduce workload for nurses [30]. Moreover,
wearable devices are promising for safe patient transports
between wards, the operating room, and the radiology
department [32]. However, these devices are still underutilized
in health care, even though they have been shown to be accurate
[17,33], and may reduce costs [34]. Despite many potential
advantages, wearable devices may have disadvantages regarding
technical dysfunction and adverse psychological effects
increasing anxiety of patients for disturbances of vital signs
[33].
Recently, ViSi Mobile (VM; Sotera Wireless) and HealthPatch
(HP; Vital Connect), two new devices approved by the US Food
and Drug Administration (FDA) for wireless remote monitoring
of vital signs, were introduced in health care. At present, little
is known about the feasibility of continuous monitoring and
experiences of patients and caregivers. The objective of this
pilot study was to assess the technical feasibility of continuous
monitoring with these new devices and to evaluate the
experiences of patients and nurses with this method of
monitoring on the general ward.
Methods
Setting and Recruitment
Patients hospitalized in the internal medicine and surgical ward
of the Radboud University Medical Center were included
between December 2014 and March 2015. All consecutively
admitted patients were approached for participation if they were
hospitalized for at least 48 hours, and MEWS measurements
were ordered at least three times a day by their medical doctor.
Patients had to be 18 years or older and able to speak, read, and
understand the local language. At the internal medicine ward,
both VM and HP were attached to the patient after signed
informed consent was obtained. At the surgical ward, patients
signed informed consent before an elective surgical procedure.
Both devices were attached to the patients after surgery and
arrival at the ward. Patients were excluded from further analyses
if they unexpectedly participated for a duration shorter than 24
hours in the study. To determine the technical feasibility and
practical usability, the two wearable devices were used to
continuously measure vital signs in patients, which were
compared with regular data collected in the same patients. Since
a formal power calculation was not feasible due to the lack of
preliminary data with these monitoring systems, a sample size
of 20 was estimated to obtain sufficient data for analysis. After
reviewing the study protocol, the institutional review board
waived the need for formal review and approval (number
2014-1434).
ViSi Mobile
The VM system has received Conformité Européenne (CE)
mark and is FDA-cleared for continuously monitoring of 3- or
5-lead electrocardiogram (ECG), heart and pulse rate, blood
oxygen saturation, RR, skin temperature, and BP (cuff-based
and cuff-less on beat-to-beat basis; Figure 1). All vital signs are
displayed on a patient-worn wrist device, which can be locked
by an authentication code. This wrist device is connected to a
thumb sensor, which measures blood oxygen saturation and BP.
A chest sensor measures RR and skin temperature, and is
connected with 3 or 5 ECG cables and sensors. In this pilot
study, VM was wirelessly connected to a stand-alone Toughbook
(Panasonic) pre-installed with VM software, from where the
investigators received real-time insights on patients’ vital signs
and where all the data were stored. This Toughbook also showed
alarms as soon as vital signs dropped out of normal ranges. The
VM wrist device was powered by rechargeable batteries, which
needed to be replaced every 12 to 14 hours.
HealthPatch
The HP consists of a reusable sensor and a disposable adhesive
patch with 2 ECG electrodes at the bottom of the patch and a
reusable sensor (see Figure 1). The HP has received CE mark
and is FDA-cleared for continuous measurement of single-lead
ECG, HR, heart rate variability (HRV), RR, skin temperature,
body posture, fall detection, and activity. This small and
lightweight patch can be attached to the patient’s chest, from
where the data is transmitted to a mobile device (eg, mobile
phone, via Bluetooth). Wi-Fi connection facilitates data
transmission from the mobile device to a secured cloud server.
The patch is powered by a coin-cell battery that lasts 3 to 4 days.
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Figure 1. ViSi Mobile system (left) and HealthPatch (right).
Study Procedures
Patients gave verbal and written consent after being informed
about the study protocol. Demographics including gender, age,
reason for admission, and type of surgery were collected. At
the surgical ward, VM and HP were attached to the patient after
surgery and arrival at the ward. At the internal medicine ward,
both devices were attached to the patient directly after signed
informed consent was obtained. Vital signs were continuously
measured during 2 or 3 days. This time frame was chosen to
obtain enough vital sign data for analysis and to allow patients
to get familiar with the devices. Nurses measured vital signs
three times daily according to the protocol. Trained medical
students additionally observed time-related vital signs monitored
by VM at the Toughbook and HP on the cloud server. They
marked the time points where vital signs were taken by the nurse
and manually selected the results for vital signs measured by
both devices at these time points for comparison. They also
registered the cause and duration of technical problems and
fixed them when necessary. In case of a VM alarm, the student
warned the nurse. After 2 to 3 days, the enrolled patients and
their relatives were interviewed about their experiences
regarding continuous monitoring and both wearable devices.
Nurses involved in the care of included patients were
interviewed as well.
Data Collection and Analysis
Technical Feasibility
All registered data from VM and HP were retrieved for analysis
in the Statistical Package for the Social Sciences version 20.0
(SPSS, Inc). Data of both devices were compared with
measurements by nurses at the same time points. For each
variable, the accepted discrepancy between nurse measurements
and both devices was determined, which are listed in Table 1.
These thresholds were defined as the maximum possible
discrepancy in vital signs between the nurse measurements and
both devices that would not lead to a change in medical
treatment. A difference in MEWS score of 1 point or more
between the nurse measurements and both devices was defined
as a clinically relevant difference. The MEWS scores were
calculated using vital signs measured by the nurses, VM, and
HP. As VM and HP did not measure all required vital signs to
calculate the MEWS score, such as level of consciousness, these
vital signs were taken from the electronic health records (EHR).
Bland-Altman plots [35] were created to assess the agreement
between MEWS measurements by nurses and corresponding
values of VM and HP. All artifacts ≥1 minute were analyzed,
since we reasoned that artifacts of less than one minute would
not be clinically relevant for a patient’s situation. An artifact
had occurred if no or an invalid value was recorded. Since
trained medical students were not present all the time (primarily
not during out-of-office hours), artifacts were divided into two
groups, depending on the presence of a student.
Table 1. Accepted discrepancies between nurse measurements, ViSi Mobile, and HealthPatch.
Accepted discrepancyVital sign
5 beats/minHeart rate
2 breaths/minRespiratory rate
2%Oxygen saturation
0.5˚CTemperaturea
5 mm HgBlood pressure
1MEWS
aViSi Mobile and HealthPatch measure skin temperature.
JMIR Mhealth Uhealth 2017 | vol. 5 | iss. 7 | e91 | p.3http://mhealth.jmir.org/2017/7/e91/
(page number not for citation purposes)
Weenk et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
Practical Usability
User experiences were obtained by means of semistructured
face-to-face interviews, after the patients had used the devices
for 2 to 3 days. Patients’ relatives and nurses were also
interviewed. Interviews lasted approximately 10 minutes and
the following topics were discussed: feelings of unsafety or
safety, user friendliness, adverse events, and detection of clinical
deterioration. One researcher (MW) performed a thematic
content analysis to determine perceived positive and negative
effects, and facilitators and barriers, which was critically
reviewed by a second researcher (TB). Perceived positive and
negative effects were presented according to the Donabedian
framework for the quality of health care [36], which includes
three main domains: structure, process, and outcome. Facilitators
and barriers were divided into four domains: characteristics
related to the patient, professional, intervention, and context
[37].
Results
Demographics
A total of 25 patients were invited, of which 20 participated in
the study—10 patients at the surgical ward and 10 patients at
the internal medicine ward. The other 5 patients refused
participation because they thought it would be too much of a
mental or physical burden (see Figure 2). The study population
included 13 males and 7 females with a mean age (standard
deviation, SD) of 49.9 (13.4) years, ranging between 33 and 82
years. At the surgical ward, most patients were admitted for an
elective gastrointestinal operation. Patients at the internal
medicine ward were admitted for several conditions such as
sepsis, arthritis, and blood pressure control.
Technical Feasibility
In total, 120 vital sign measurements by nurses were observed
by the trained medical students (see Figure 2). In 40
measurements, one or more vital signs were missing. In 6
measurements, data were completed by consulting the EHR.
As a result, 86 measurements were used for further analysis.
For the remaining 34 measurements, VM and HP data were
lacking (25 measurements), or vital signs were not documented
by nurses (9 measurements). In 8 patients, data from the
Toughbook was not available for further analysis due to
accidental deletion of data; in 2 patients, no HP data were saved
at the cloud server due to technical failures (eg, WiFi failures,
disconnection between HP and its mobile device). In total, 742.8
hours of VM data and 1033.6 hours of HP data were collected;
on an average 61.9 hours of VM and 57.5 hours of HP data were
collected per patient.
Figure 2. Included patients and vital sign measurements.
JMIR Mhealth Uhealth 2017 | vol. 5 | iss. 7 | e91 | p.4http://mhealth.jmir.org/2017/7/e91/
(page number not for citation purposes)
Weenk et alJMIR MHEALTH AND UHEALTH
XSL•FO
RenderX
Figure 3. Bland-Altman plots: (a) heart rate (VM and HP), (b) respiratory rate (VM and HP), (c) systolic and diastolic blood pressure (VM). Dotted
lines indicate mean difference and solid lines indicate limits of agreement.
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Figure 4. Bland-Altman plots showing modified early warning score: (a) VM and HP, (b) VM and HP (jittered). Dotted lines indicate mean difference
and solid lines indicate limits of agreement.
Vital Signs
Bland-Altman plots showing the mean of the two devices and
the differences between the two devices (y-axis) with limits of
agreement (1.96 SD) are displayed in Figures 3 and 4.
Comparing the results for vital signs and MEWS score measured
by nurses and VM, the mean differences were all within range
with the predefined accepted discrepancies in Table 1, although
wide limits of agreement were found (see Table 2). The largest
discrepancy in the mean difference was found for diastolic BP.
In 13 (15%) cases, the MEWS difference between nurse and
VM was 2 points or higher, indicating important clinical
differences between VM and nurse measurements (see Table
3). In four cases, this was related to differences in RR alone. In
the remaining cases, the combination of RR and oxygen
saturation, or RR and systolic BP caused the difference.
Moreover, in six of these cases, VM measured a higher RR than
nurses (range: 1-6 breaths/min), and in the four other cases,
nurses measured a higher RR than VM (difference: 2-6
breaths/min). In the three remaining cases that resulted in a
different MEWS, there was a difference in systolic BP
(difference: 14 mm Hg) or oxygen saturation (difference:
1%-5%) between VM and the nurse. The mean differences
between nurse measurement and HP were all in agreement with
accepted discrepancies, although wide limits of agreement were
found (see Table 2). In 23 (27%) cases, MEWS differed 2 or 3
points between HP and nurse measurements (see Table 3). In
17 cases, HP measured higher RR compared with nurses. In 16
cases, differences were in the range of 3 to 8 breaths/minute.
However, in one case, nurses measured 16 breaths/minute and
HP measured 42 breaths/minute, indicating possible
measurement errors in HP. In the remaining six cases, nurses
measured a higher RR than HP (difference: 4-12 breaths/min).
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Table 2. ViSi Mobile and HealthPatch data in comparison with corresponding nurse measurements.
HealthPatchViSi MobileNurseVital signs
Mean difference (SD)
versus nurse
Mean (SD)Mean difference (SD)
versus nurse
Mean (SD)Mean (SD)j
−1.52c (5.63)84.34 (12.24)−0.20 (5.54)81.62 (12.23)81.81 (13.12)HRf (beats/min)
−0.64 (4.94)18.02 (5.82)1.19a (3.43)16.20 (4.57)17.38 (3.89)RRg (breaths/min)
N/AN/Ak0.10 (1.65)97.00 (95.00 to 98.00)d97.00 (96.00 to 98.00)dSaturation (%)
34.16 (1.16)e33.61(1.25)e37.01 ( 0.60)Temperature (˚C)
N/AN/A0.44 (11.99)127.49 (18.68)127.93 (19.33)BPh, systolic (mm Hg)
N/AN/A
−8.00b (9.93)81.17 (11.24)73.17 (10.25)BP, diastolic (mm Hg)
−0.60b (1.22)1.59 (1.54)−0.40a (1.13)1.38 (1.30)0.99 (1.13)MEWSi
aP=.002.
bP<.001.
cP=.01.
dOxygen saturation was reported as median with interquartile range.
eSkin temperature.
fHR: heart rate.
gRR: respiratory rate.
hBP: blood pressure.
iMEWS: modified early warning score.
jSD: standard deviation.
kN/A: Not applicable.
Artifacts
ViSi Mobile
In total, 306 artifacts were found, with a total time of 121 hours.
In 111 (36.3%) of 306 artifacts, a trained medical student was
present, and 86 of 111 (77.5%) were identified and reported. A
cause was found in 82 (95.1%) of 86 artifacts. Almost 70% of
all reported artifacts were caused by connection failure between
Toughbook and VM. Other artifact causes were motion of the
sensors due to patient movements (n=21, 25.6%) and required
calibration of blood pressure (n=2, 2.3%). Over 74% of all
artifacts lasted less than 5 minutes. Almost 20% lasted less than
1 hour, and approximately 7% lasted longer than 1 hour.
HealthPatch
In total, 648 artifacts were found in 18 patients, with a total time
of 135 hours. More than 50% (n=354) of all artifacts lasted less
than 1 minute and were excluded from further analysis. In the
remaining 294 artifacts, a trained medical student was present
in 60% (n=176) of the artifacts, and identified and reported the
artifact in 53 (30%) cases. A cause was found in 24 (45%)
artifacts such as HealthPatch losing skin contact (n=13, 54%),
Bluetooth (n=4, 17%) or Wi-Fi problems (n=3, 13%), and
patients leaving the ward without their mobile device (n=3,
13%). Around 43% of all artifacts lasted less than 5 minutes.
Over 95% of all artifacts lasted less than 1 hour.
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Table 3. ViSi Mobile (VM) and HealthPatch (HP) data in comparison with corresponding nurse measurements.
HealthPatchViSi MobileVital signs
Difference; nurse-HP (%)Difference; nurse-VM (%)
≤5: 65 (75.6)≤5: 71 (82.5)HRa (beats/min)
6-10: 16 (18.6)6-10: 12 (14.0)
>10: 5 (5.8)>10: 3 (3.5)
≤2: 36 (41.9)≤2: 50 (58.2)RRb (breaths/min)
3-5: 31 (36.0)3-5: 26 (30.2)
>5: 19 (22.1)>5: 10 (11.6)
N/Ae≤2: 76 (88.4)Saturation (%)
3-4: 9 (10.5)
≥5: 1 (1.1)
N/A≤5: 36 (41.9)BPc systolic (mm Hg)
6-14: 33 (38.4)
≥15: 17 (19.7)
N/A≤5: 27 (31.4)BP diastolic (mm Hg)
6-14: 40 (46.5)
15: 19 (22.1)
−3: 9 (10.5)−4: 1 (1.2)MEWSd
−2: 11 (12.8)−3: 5 (5.8)
−1: 13 (15.1)−2: 4 (4.7)
0: 47 (54.7)−1: 23 (26.7)
1: 3 (3.5)0: 40 (46.5)
2: 2 (2.3)1: 10 (11.6)
3: 1 (1.2)2: 3 (3.5)
aHR: heart rate.
bRR: respiratory rate.
cBP: blood pressure.
dMEWS: modified early warning score.
eN/A: not applicable.
Practical Usability
Evaluations were performed with all 20 patients, 7 relatives,
and 4 nurses (see Table 4).
Perceived Positive and Negative Effects
Processes
One positive effect was identified in this dimension. Patients
stated that nurses could keep an eye on the vital signs from a
distance (n=3); this was also mentioned by one relative. No
negative effects were identified.
Outcomes
Two positive effects were identified in this dimension. Eight
patients and 66 relatives mentioned increased feelings of safety
by being monitored continuously in comparison with the MEWS
measurements by nurses only. A patient described:
Being monitored continuously is a very pleasant
experience; I felt very safe. [Translated from Dutch]
Earlier interventions were deemed possible in case of clinical
deterioration (n=3). One negative effect was identified; one
patient complained about having redness and itching while
wearing the devices.
Facilitators and Barriers
Intervention
Seven facilitators were identified. Eight patients said they were
not aware of the HP while it was attached to their chest. Other
facilitators included not being restricted by the devices during
daily activities such as bathing and putting on clothes (n=3),
more freedom of movements compared with conventional
devices (n=2), the small size of the HP (n=1), the good adhesive
properties of the patches (n=1), and the invisibility of the devices
under clothes (n=1). One patient described:
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I have used a holter monitor at home several times.
These devices are much smaller and they do not limit
mobility to the same extent. [Translated from Dutch]
One patient experienced great advantage of having an insight
on his own vital signs. One barrier was noted 15 times. Patients
mentioned that the VM wrist device was big or heavy (n=10);
patches came off very quick (6 VM; 2 HP); VM had many cables
(n=4); and VM had a short battery life (n=2).
Professional
Two facilitators and one barrier were identified in this domain.
Two nurses stated that the patches did not lose skin contact
while washing the patient, and one nurse said that it was very
easy to attach the devices to the patient. One nurse mentioned
that Wi-Fi connection was poor between Toughbook and the
VM device.
Additional Findings
During the study, clinical deterioration was detected with the
VM in one patient 3 days postoperatively after elective colorectal
surgery. The device alerted the nurse who cared for the patient
because he developed a tachycardia and tachypnea. This
situation occurred between two regular measurements. He
underwent relaparotomy after an anastomotic leak was
confirmed by computer tomography.
Table 4. Users’ experiences.
RelativesPatientNurseUsers’experience
Perceived positive and negative effects
Processesa
++Nurse could keep eye on vital signs more easily
Outcomes
++Feelings of safety
+Earlier interventions
−Adverse events (redness and itching)
Barriers and facilitators
Intervention
+Not aware of HPb
+Small size of HP
+Good adhesive properties
+Not being restricted during daily activities
+More freedom of movements
+Invisibility under clothes
+Better insight on own vital signs
−VMc wrist device too big/heavy
−Patches came off very quickly
−VM has too many cables
−Short VM battery life
Professional
+Good adhesive properties
+Very easy to attach the devices
−Bad Wi-Fi connection between VM and Toughbook
aNo positive or negative effects in the “Structure” or “Context” fields were found.
bHP: HealthPatch.
cVM: ViSi Mobile.
Discussion
Principal Findings
This study describes a unique approach in which we
continuously measured vital signs on the ward using two
recently released wireless devices. In general, data obtained by
these devices correlated well with predefined accepted
discrepancies and MEWS calculated on the basis of these
devices correlated to a larger extent. Patients and nurses were
mainly positive about the two devices. Both VM and HP are
promising devices for continuous patient monitoring on the
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general ward. However, the number of artifacts should be
reduced and the barriers mentioned by the users could be
addressed to further improve both devices.
Vital Signs
The largest discrepancy in mean difference was found in VM
diastolic blood pressure, which is unlikely to be directly
clinically meaningful since it is not a component of the MEWS.
Additionally, clinical decisions are mainly based on systolic
blood pressure and other vital signs. Wide limits of agreement
were found for almost all vital signs and MEWS. Although
more than 70% of all MEWS differed 0 or only 1 point between
devices and nurse measurements, larger differences in MEWS
were found in a few cases, which may have important clinical
consequences (eg, additional diagnostic procedures or change
in treatment). In most of these cases, VM and HP measured a
higher RR when nurses did not. Although most differences
between nurse and device measurements were small (<5
breaths/min), in one case, difference between nurse and HP
measurements was large (26 breaths/min). These findings are
important as abnormal RR has been shown to be an important
predictor of cardiac arrest [38] and an indicator of sepsis,
pneumonia and respiratory depression [39]; therefore, it could
under- or overestimate a clinical condition of a patient.
Inaccurate RR measurements by nurses could explain the
discrepancy. Direct measurement of RR is usually done by
visually observing chest movement or by manual observations.
Reproducibility may be limited by significant interobserver
variability [40]. Conversely, ECG-derived RR measurements
by HP and VM may be inaccurate. In case of HP, RR is
estimated by ECG using the respiratory sinus arrhythmia
method, which derives RR from HRV. Since this method has
some limitations, an accelerometer was added to measure RR
more accurately [41]. In VM, RR is derived from impedance
pneumography, measuring respiratory volume and rate through
the relationship between respiratory depth and thoracic
impedance rate [42]. ECG-derived RR may not be accurate
when there is excessive patient motion or during lower
respiratory rates [43,44]. More research is required to gain a
deeper insight in the different methods of measuring RR by
devices and nurses.
Artifacts
Most reported that VM artifacts concerned connectivity failure
between VM and Toughbook. This was caused by a restricted
Wi-Fi connection of approximately 15 meters between VM and
Toughbook, which explains why more artifacts were found in
mobile patients. These artifacts were not deemed relevant since
more stable Wi-Fi connections, such as by using multiple access
points and 5 Ghz networks, would be used to implement VM
in a hospital setting. This would also facilitate continuous
monitoring during patient transport between different wards.
However, it is important to consider that a wireless connection
can always fail, thus proper backup power and Internet
connections are always demanded. Most HP artifacts were of
unknown cause. However, most artifacts lasted less than one
hour and were self-limiting.
Although HP could not measure all vital signs that are currently
used to monitor patients and to calculate the MEWS, it may still
provide more patient data than interval measurements by nurses,
resulting in a more continuous dataflow and more specific
trends. This may be of significance, in particular, since literature
shows important lack of documentation of vital signs before a
life-threatening event [27]. Besides that, several studies show
that HR and RR change significantly before ICU transfer,
cardiac arrest, and mortality and therefore, HP can have a
valuable contribution to the prediction of life-threatening events
[24,27].
Practical Usability
The majority of patients, relatives, and nurses were positive
about VM and HP. Whereas HP is able to administer vital signs
in real time to patient’s mobile phone, VM shows vital signs in
real time on the wrist device; these devices could therefore
increase insight on patient’s health status and potentially
influence their behaviors [45,46]. Although patients mentioned
that the VM wrist device was heavy and VM consisted of many
cables, they were not restricted during daily activities or
mobility. This is important as hospitalized patients benefit from
mobility, resulting in increased recovery and reduced risk of
complications [47,48]. Another benefit of VM and HP is that
nurses are able to see patients’ vital signs from a distance. A
review by Ulrich et al [49] has shown that sleep deprivation in
patients is a common problem that is associated with hindrance
of the healing process and an increase in morbidity and
mortality. Using VM and HP, patients could continue sleeping
during the night and did not have to be disturbed by vital sign
measurements.
Possible negative aspects of continuous monitoring should also
be taken into consideration. Wearable devices generate a large
quantity of data each day. The workload of nurses and
physicians withholds them from inspecting all these data, which
means that the predictive value of continuous monitoring is lost
[17]. Validated devices are available to process all these data
and to send an alert when patient’s vital signs drop out of normal
ranges. A large number of alerts and even false-positive alerts
could cause alarm-fatigue in nurses [17,50]. Algorithms using
machine learning could be utilized to reduce false-positive
alarms [51-53]. The VM battery has a battery life of 12 to 14
hours, which means that nurses have to change batteries twice
a day. This might outweigh the fact that nurses no longer need
to perform the standard MEWS measurements three times a
day.
Comparison With Prior Work
A few studies about continuous monitoring at the general ward
have been published. A wireless sensor was successfully used
in pregnant women in an inpatient obstetric unit, which was
able to monitor HR, RR, and temperature [30]. Recently, the
SensiumVitals digital patch was tested in hospitalized patients
[54]. This patch is able to measure HR and RR and was
compared with a commonly used clinical monitor. A satisfactory
agreement, comparable with the result in our study, was shown.
The drawback of the study design was that the patients were
monitored for only 2 hours, which prevented the authors from
detecting trends in vital signs and lowered predictive value. The
use of an implantable device for continuous monitoring has
been described in the ambulatory setting. Abraham et al [55]
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described the use of a wireless implantable hemodynamic
monitoring system in heart failure patients, which has shown
to reduce hospitalization. Wireless technology systems in which
patients measure vital signs at home have been described, such
as for patients with chronic obstructive pulmonary disease [56],
patients with hypertension [57], and patients with diabetes
mellitus [58,59]. These systems were often well received by
patients and health care providers, showing improvement of
blood values such as glucose [58,60], patients’ disease
management [56,61], and better connection between the patient
and the health care provider [59]. Particularly, the HP might be
suitable for home monitoring, although its current version lacks
the possibility to measure all vital signs. Though VM measures
all vital signs, its size and cables might demand much from
patients to enable monitoring at home.
Strength and Limitations
An important strength of the study is that we were able to
monitor patients in a clinical setting instead of healthy
participants in controlled settings. The study had a small sample
size, and we missed some VM and HP data, particularly since
VM data of 8 patients were automatically deleted from the
Toughbook and could not be used for artifact analysis. This was
due to wrong Toughbook settings and was changed with support
from the manufacturer. The VM vital signs observed by students
were used for the comparison with nurse measurements, and
we were therefore able to draw conclusions about the feasibility
of both VM and HP. However, data saturation in patient, nurse,
and relative interviews may not have been reached. Selection
bias could have occurred as not all patients who were
approached did agree to participate. A further limitation of VM
and HP is that both devices measure skin temperature instead
of body temperature. Although it is not yet clear whether or not
all vital signs are necessary for proper clinical judgment of ill
patients, an algorithm should be developed to convert skin
temperature into body temperature.
Conclusions
The VM and HP are promising devices for wireless continuous
patient monitoring in the hospital and were very well received
by both patients and nurses. The frequency and duration of
artifacts should be reduced and the barriers mentioned could be
addressed to further improve VM and HP. An ongoing follow-up
study focuses on the different effects of VM or HP compared
with routine MEWS measurements on patient comfort and safety
and nurse workload, and on early detection of deterioration.
Future studies should focus on the effect of continuous
monitoring on clinical outcome.
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